Senores Pharmaceuticals has informed that Havix Group Inc. D/B/A Aavis Pharmaceuticals (‘Havix’), a Material Subsidiary of the Company situated at 9488 Jackson Trail Road, Hoschton, Georgia 30548, USA has completed the United States Food & Drug Administration (‘USFDA’) inspection of its manufacturing facility from July 21, 2025 to July 25, 2025 with 3, 483 observations. These observations are procedural and minor in nature and Havix will respond to these observations within 15 days.
The above information is a part of company’s filings submitted to BSE.
